Clinical Trials Logo

Clinical Trial Summary

Individual patient expanded access requests may be considered for patients who have no other treatment options


Clinical Trial Description

Expanded access may be available outside of the US in countries prior to approval by the local regulatory agencies. For full details, please visit the links provided below. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03775174
Study type Expanded Access
Source Ultragenyx Pharmaceutical Inc
Contact Early Access
Phone 1-415-483-8800
Email EarlyAccess@ultragenyx.com
Status Available
Phase

See also
  Status Clinical Trial Phase
Recruiting NCT05687474 - Baby Detect : Genomic Newborn Screening
Completed NCT02432144 - A Study of UX003 Recombinant Human Beta-Glucuronidase (rhGUS) Enzyme Replacement Therapy in Subjects With Mucopolysaccharidosis Type 7, Sly Syndrome (MPS 7) Phase 3
Recruiting NCT05619900 - Registry of Patients Diagnosed With Lysosomal Storage Diseases
Enrolling by invitation NCT05368038 - ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program
Completed NCT02418455 - Study of UX003 Recombinant Human Beta-Glucuronidase (rhGUS) Enzyme Replacement Treatment in Mucopolysaccharidosis Type 7, Sly Syndrome (MPS 7) Patients Less Than 5 Years of Age Phase 2
Recruiting NCT03604835 - Mucopolysaccharidosis VII Disease Monitoring Program
Recruiting NCT06036693 - MPS (RaDiCo Cohort) (RaDiCo-MPS)